Achievement of complete morphological regression in the use of trastuzumab in patients with inoperable locally advanced Her-2+ breast cancer

by K. R. Zeinalova, Ya. V. Vishnevskaya, I. P. Ganshina
Published 2014-07-01

Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?

by O. O. Gordeeva, L. G. Zhukova, I. V. Kolyadina, I. P. Ganshina
Published 2019-04-01

Ribociclib in 1st line HR+ breast cancer treatment

by L G Zhukova, I P Ganshina, O O Gordeeva, E V Lubennikova
Published 2018-06-01

Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?

by L G Zhukova, I P Ganshina, E I Khatkova, T E Tikhomirova, O E Kondratyeva
Published 2018-06-01

Olaparib in the metastatic HER2-negative breast cancer setting

by L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova
Published 2020-12-01

Dermatomyositis and polymyositis in breast cancer patients: a case reports

by I P Ganshina, L G Zhukova, E Z Burnevitch, O O Gordeeva, O E Kondratieva
Published 2018-03-01

Znachenie HER-2/NEU pri rake zheludka

by A N Lud, Yu V Vakhabova, N N Semenov, I P Gan'shina, E V Stepanova
Published 2010-06-01

Ribociclib for the treatment of hormone-positive HER2-negative breast cancer

by I. P. Ganshina, D. A. Filonenko, O. O. Gordeeva, E. V. Lubennikova, I. V. Kolyadina, A. A. Mescheryakov
Published 2019-06-01

ASSOCIATION OF NKT- AND ACTIVATED CD25⁺ PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS

by A. I. Chertkova, E. G. Slavina, T. N. Zabotina, Z. G. Kadagidze, E. K. Shoua, O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Gan’shina, A. A. Meshcheryakov
Published 2020-12-01

Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case

by I V Kolyadina, I P Ganshina, L G Zhukova, A G Abdullaev, Yu Yu Andreeva, T Yu Danzanova, G T Sinyukova, D V Komov, N A Kozlov, D A Filonenko, O O Gordeeva, E V Lubennikova
Published 2017-12-01

Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0

by O A Pavlikova, I V Poddubnaya, I V Kolyadina, A Guseynovich Abdullaev, D V Komov, T Yu Danzanova, G T Sinyukova, N A Kozlov, I P Ganshina, L G Zhukova, G S Aliyeva, R A Kerimov, O O Gordeeva
Published 2017-12-01

Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series

by R V Orlova, L G Zhukova, I P Ganshina, D Yu Yukalchuk, D M Ponomarenko, N P Beliak, O O Gordeeva, S P Erdniev, A A Minasyan, A A Dashkova, E R Sopiya, E A Sholokhova, A B Gurochkin
Published 2018-03-01

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer

by O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov
Published 2020-11-01

EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FEDERATION

by E. V. Lubennikova, I. P. Ganshina, A. N. Lud, D. V. Komov, I. V. Kolyadina, Y. V. Vishnevskaya, I. K. Vorotnikov, D. L. Stroyakovsky, N. A. Savelov, V. F. Semiglazov, А. G. Manikhas, А. V. Osheychik, T. B. Strelnikova, K. R. Zeynalova, L. G. Zhukova
Published 2017-11-01

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer

by T. Yu. Semiglazova, E. V. Lubennikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, A. V. Avramenko, E. V. Artemeva, S. A. Borozdina, A. A. Vakhitova, N. M. Volkov, I. P. Ganshina, Sh. A. Dzhalilova, L. G. Zhukova, B. S. Kasparov, A. A. Kachmazov, V. V. Klimenko, A. i. Kornietskaya, A. A. Meshcheryakov, A. A. Paichadze, A. N. Poltoratsky, O. E. Ryabishina, M. L. Stepanova, E. N Imyanitov
Published 2020-12-01